A detailed history of Morgan Stanley transactions in Guardant Health, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,101,592 shares of GH stock, worth $29.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,101,592
Previous 2,458,282 55.19%
Holding current value
$29.9 Million
Previous $66.5 Million 65.83%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $23.2 Million - $36.5 Million
-1,356,690 Reduced 55.19%
1,101,592 $22.7 Million
Q4 2023

Feb 13, 2024

BUY
$21.58 - $29.5 $6.53 Million - $8.93 Million
302,602 Added 14.04%
2,458,282 $66.5 Million
Q3 2023

Nov 15, 2023

BUY
$25.8 - $39.97 $11.1 Million - $17.2 Million
429,749 Added 24.9%
2,155,680 $63.9 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $384,604 - $698,129
18,367 Added 1.08%
1,725,931 $61.8 Million
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $80.4 Million - $118 Million
-3,507,945 Reduced 67.26%
1,707,564 $40 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $5.67 Million - $13.3 Million
222,807 Added 4.46%
5,215,509 $142 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $7.14 Million - $9.97 Million
-163,494 Reduced 3.17%
4,992,702 $269 Million
Q2 2022

Oct 27, 2022

SELL
$28.82 - $77.35 $10.1 Million - $27.1 Million
-350,373 Reduced 6.36%
5,156,196 $208 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $10.1 Million - $27.1 Million
-350,373 Reduced 6.36%
5,156,196 $208 Million
Q1 2022

Oct 27, 2022

BUY
$48.25 - $100.49 $16.9 Million - $35.2 Million
350,373 Added 6.8%
5,506,569 $365 Million
Q1 2022

May 13, 2022

SELL
$48.25 - $100.49 $15.2 Million - $31.6 Million
-314,210 Reduced 5.4%
5,506,569 $365 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $23.1 Million - $31.3 Million
260,138 Added 4.68%
5,820,779 $582 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $549 Million - $735 Million
5,560,641 New
5,560,641 $695 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.77B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.